national-bank-of-commerce-of-el-dorado-arkansas-guardian-of-the-estate , 133 F.3d 1132 ( 1998 )
Menu:
-
133 F.3d 1132
NATIONAL BANK OF COMMERCE, OF EL DORADO, ARKANSAS, Guardian
of the Estate (only) of Ashley Marie Smits, A Minor;
William J. Smits, Jr., Individually, and as Parent and Next
Friend of Ashley Marie Smits, A Minor, Appellants,
v.
DOW CHEMICAL COMPANY; Steam Services, Inc.; Rofan
Services, Inc.; [PUBLISHED] EPCO, Inc. of Indiana,
doing business as DowElanco, Appellees.No. 97-1755.
United States Court of Appeals,
Eighth Circuit.Submitted Dec. 11, 1997.
Decided Jan. 22, 1998.Bobby Davidson, Little Rock, AR (Bernard Whetston, Kevin Odum and Robert C. Compton, on the brief), for Appellants.
Robert D. MacGill, Indianapolis, IN, argued (Joseph G. Eaton, Stanley C. Fickle and William E. Padgett, Indianapolis, IN, Sammye L. Taylor and Troy A. Price, Little Rock, AR, on the brief) for Appellees Dow Chemical, Rofan Services, Inc. and Epco, Inc.
Michael J. Emerson, Little Rock, AR, argued (Robert L. Henry, III, on the brief), for Steam Services, Inc.
Before FAGG, BEAM, and MORRIS SHEPPARD ARNOLD, Circuit Judges.
PER CURIAM.
1Ashley Smits was born with severe birth defects. During her pregnancy, Ashley's mother had been exposed to Dursban LO (a pesticide) and Firefog 404 (a reoderant). Plaintiffs filed suit against various defendants contending that these chemical agents, either singly or in combination, were the cause of Ashley's abnormalities. Plaintiffs retained experts who were willing to testify that the mother's exposure to Dursban LO and Firefog 404 proximately caused Ashley's birth defects. After extensive discovery, depositions, numerous court hearings, including two full days of testimony, the district court1 ruled that the testimony of plaintiffs' experts was not admissible as scientific evidence under Federal Rules of Evidence 702 and 703. Specifically, the court concluded that the plaintiffs had not shown that the proffered testimony had a valid scientific foundation, as required by the Supreme Court in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), because it was not based on accepted scientific methodology for determining whether a chemical agent can cause birth defects in humans. The district court granted summary judgment for all defendants.
2Although we may not agree with the district court's analysis of Daubert in every detail, we find no abuse of discretion. See General Elec. Co. v. Joiner, --- U.S. ----, 118 S.Ct. 512, 139 L.Ed.2d 508 (1997). Given the complete analysis of the facts and the law by the district court, precedent of this circuit would not be substantially advanced by a detailed opinion by the court. See 8th Cir. Rule 47B. The decision of the district court is affirmed.
1The Honorable G. Thomas Eisele, United States Judge for the Eastern District of Arkansas
Document Info
Docket Number: 97-1755
Citation Numbers: 133 F.3d 1132, 1998 U.S. App. LEXIS 807
Filed Date: 1/22/1998
Precedential Status: Precedential
Modified Date: 3/3/2016